PPARγ plays a central regulatory role in enhancing fatty acid synthesis and β-oxidation in lung cancer, and pioglitazone induces PPARγ activation and promotes de novo fatty acid synthesis and β-oxidation. The gene discussed is PPARG; the disease is lung cancer.